Stark Law

Final Deadline: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Lead Plaintiff Deadline in Securities Fraud Class Action Lawsuit Filed against Fulgent Genetics, Inc. (FLGT)

Retrieved on: 
Sunday, November 20, 2022
COVID-19, COPY, Central District, Stark Law, U.S. Department of Justice Office of Legislative Affairs, LLP, Disclosure, Anti-Kickback Statute, Insurance, Health, Stark, Physician, Genetics, Patient, Lead, Reward, Battle of Saint-Fulgent, Office of Inspector General, U.S. Department of Health and Human Services, District court, News, Medicare, Justice, Genetic testing, Fraud, Remuneration, Private investigator, Pharmaceutical industry, Architecture

Kessler Topaz Meltzer & Check, LLP encourages Fulgent investors who have suffered significant losses to contact the firm directly to acquire more information.

Key Points: 
  • Kessler Topaz Meltzer & Check, LLP encourages Fulgent investors who have suffered significant losses to contact the firm directly to acquire more information.
  • The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel.
  • ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP
    Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts throughout the country and around the world.
  • The complaint in this action was not filed by Kessler Topaz Meltzer & Check, LLP.

FLGT 2-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Fulgent Genetics (FLGT) Investors with Significant Losses to Contact the Firm’s Attorneys Before Nov. 21st Deadline in Securities Class Action

Retrieved on: 
Saturday, November 19, 2022
SAN, Disclosure, Steve Berman (lawyer), Stark Law, Genetics, News, DOJ, Person, Fraud, Pharmaceutical industry, Tobacco, Battle of Saint-Fulgent

SAN FRANCISCO, Nov. 19, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Fulgent Genetics, Inc. (NASDAQ: FLGT) investors who suffered significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Nov. 19, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Fulgent Genetics, Inc. (NASDAQ: FLGT) investors who suffered significant losses to submit your losses now .
  • A securities fraud class action has been filed after Fulgent disclosed the DOJ and SEC are conducting investigations.
  • Fulgent Genetics, Inc. (NASDAQ: FLGT) Securities Fraud Class Action:
    The litigation focuses on Fulgents previously claimed very strong and truly outstanding financial results.
  • If you invested in Fulgent and have significant losses, or have knowledge that may assist the firms investigation, click here to discuss your legal rights with Hagens Berman .

FLGT DEADLINE ALERT: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Fulgent Genetics, Inc. Investors to Secure Counsel Before Important Monday Deadline in Securities Class Action – FLGT

Retrieved on: 
Friday, November 18, 2022
Titan, Advertising, Health, Stark Law, Genetics, Class, I-Space (Chinese company), Federal, Court, Reward, Battle of Saint-Fulgent, Medicare, Anti-Kickback Statute, Remuneration, Insurance, Tobacco, Pharmaceutical industry

WHAT TO DO NEXT: To join the Fulgent Genetics class action, go to https://rosenlegal.com/submit-form/?case_id=8809 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Fulgent Genetics class action, go to https://rosenlegal.com/submit-form/?case_id=8809 or call Phillip Kim, Esq.
  • WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

Lifshitz Law PLLC Announces Investigations of Kohls Corporation (NYSE: KSS), Sema4 Holdings Corporation (NASDAQ: SMFR), Palantir Technologies, Inc. (NYSE: PLTR), and Fulgent Genetics, Inc. (NASDAQ: FLGT)

Retrieved on: 
Friday, November 18, 2022
Growth, Disclosure, Telephone, Risk, Stark Law, Government, Hewlett, Complaint, Defendant, EPS, Advertising, Battle of Saint-Fulgent, Anti-Kickback Statute, Investment, Remuneration, Risk management, Mail, Pharmaceutical industry, Palantir Technologies, Kohl's

If you are an Kohls investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq.

Key Points: 
  • If you are an Kohls investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq.
  • If you are a Sema4 investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq.
  • Lifshitz Law PLLC announces that a class action complaint was filed on behalf of shareholders of Palantir alleging that Defendants made materially false and misleading statements regarding the Companys business, operations, and prospects.
  • The law firm responsible for this advertisement is Lifshitz Law PLLC, 1190 Broadway, Hewlett, New York 11557, Tel: (516)493-9780.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Fulgent, Yatsen, Barclays, and Warner Bros. and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, November 17, 2022
Health, Stark Law, Defendant, HBO, Warner Bros., U.S. Department of Defense Strategy for Operating in Cyberspace, AT&T, Justice, ADS, Remuneration, Genetics, Patient, Complaint, Prospectus, Register, Battle of Saint-Fulgent, Anti-Kickback Statute, COVID-19, U.S. Department of Justice Office of Legislative Affairs, Mergers and acquisitions, Physician, Annual report, Warner, BCS, Reward, AT, News, NYSE, Genetic testing, HBO Max, YSG, Disclosure, Turnaround ADR, ADR, Section 11 of the Canadian Charter of Rights and Freedoms, IPO, Federal, Medicare, Sale, Investment, Pharmaceutical industry, Music, Audit, Security (finance), P.C, Discovery, Barclays, WarnerMedia

Fulgent, together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally.

Key Points: 
  • Fulgent, together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally.
  • The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Companys business, operations, and compliance policies.
  • For more information on the Warner Bros. class action go to: https://bespc.com/cases/WBD
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fulgent Genetics, Inc. (FLGT)

Retrieved on: 
Wednesday, November 16, 2022
Exchange, U.S. Department of Justice Office of Legislative Affairs, Stark, Stark Law, GPM, Genetics, Defendant, Court, Privacy Office of the U.S. Department of Homeland Security, News, Anti-Kickback Statute, Justice, Suite, Investment, Remuneration, Pharmaceutical industry, Battle of Saint-Fulgent

You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.

Key Points: 
  • You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.
  • If you purchased or otherwise acquired Fulgent securities during the Class Period, you may move the Court no later than November 21, 2022 to request appointment as lead plaintiff in this putative class action lawsuit.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
  • Glancy Prongay & Murray LLP, Los Angeles

DEADLINE ALERT for FLGT, YSG, BCS, and OLO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on: 
Tuesday, November 15, 2022
Law, Stark Law, Genetics, IPO, Defendant, Battle of Saint-Fulgent, Anti-Kickback Statute, Suite, Investment, Remuneration, Security (finance), Mail, Holding company, Risk management, Barclays

LOS ANGELES, Nov. 15, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points: 
  • LOS ANGELES, Nov. 15, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
  • Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to [email protected] .
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
  • The Law Offices of Frank R. Cruz, Los Angeles

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Fulgent Genetics (FLGT) Investors with Significant Losses to Contact Firm’s Attorneys Before Nov. 21st Deadline in Securities Class Action

Retrieved on: 
Monday, November 14, 2022
Stark Law, News, Person, Disclosure, DOJ, Fraud, SAN, Genetics, Steve Berman (lawyer), Pharmaceutical industry, Tobacco, Battle of Saint-Fulgent

SAN FRANCISCO, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Fulgent Genetics, Inc. (NASDAQ: FLGT) investors who suffered significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Fulgent Genetics, Inc. (NASDAQ: FLGT) investors who suffered significant losses to submit your losses now .
  • A securities fraud class action has been filed after Fulgent disclosed the DOJ and SEC are conducting investigations.
  • Fulgent Genetics, Inc. (NASDAQ: FLGT) Securities Fraud Class Action:
    The litigation focuses on Fulgents previously claimed very strong and truly outstanding financial results.
  • If you invested in Fulgent and have significant losses, or have knowledge that may assist the firms investigation, click here to discuss your legal rights with Hagens Berman .

DEADLINE ALERT for FLGT, YSG, BCS, OLO: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on: 
Monday, November 14, 2022
Law, Investment, Stark Law, Class, Anti-Kickback Statute, Telephone, Remuneration, IPO, Defendant, Suite, Battle of Saint-Fulgent, People's Law Office, Barclays, Security (finance)

BENSALEM, Pa., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points: 
  • BENSALEM, Pa., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
  • Investors have until the deadlines listed below to file a lead plaintiff motion.
  • Investors suffering losses on their investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in these class actions at 888-638-4847 or by email to [email protected] .
  • Law Offices of Howard G. Smith

DEADLINE ALERT: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Fulgent Genetics, Inc. Securities Fraud Class Action Lawsuit

Retrieved on: 
Sunday, November 13, 2022
Stark Law, Central District, Anti-Kickback Statute, District court, Stark, Remuneration, News, Lead, U.S. Department of Justice Office of Legislative Affairs, Health, Insurance, Medicare, Physician, Justice, Disclosure, LLP, COVID-19, Fraud, Reward, Genetics, COPY, Battle of Saint-Fulgent, Genetic testing, Patient, Office of Inspector General, U.S. Department of Health and Human Services, Private investigator, Pharmaceutical industry, Architecture

Kessler Topaz Meltzer & Check, LLP encourages Fulgent investors who have suffered significant losses to contact the firm directly to acquire more information.

Key Points: 
  • Kessler Topaz Meltzer & Check, LLP encourages Fulgent investors who have suffered significant losses to contact the firm directly to acquire more information.
  • ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP
    Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts throughout the country and around the world.
  • The complaint in this action was not filed by Kessler Topaz Meltzer & Check, LLP.
  • For more information about Kessler Topaz Meltzer & Check, LLP please visit www.ktmc.com .